H-D-Pra-OH*HCl

H-D-Pra-OH*HCl is the hydrochloride salt of D-propargylglycine (D-Pra), presenting a chiral amino acid framework with a terminal propargyl side chain and a carboxylic acid functionality. The D-configuration at the α-carbon provides stereochemical control for incorporation into peptide and peptidomimetic sequences, while the propargyl group enables chemoselective transformations through alkyne reactivity. Salt formation as the HCl hydrate/complex increases handling stability and water compatibility for synthetic workflows, while the free carboxylic acid and amino functionality (as a protonated salt) support standard amino acid coupling and derivatization strategies after appropriate neutralization or activation. The combination of an amino acid backbone with a reactive alkyne side chain makes this compound a practical chiral intermediate for peptide building block preparation and downstream functional group installation.

1. Peptide Synthesis

H-D-Pra-OH*HCl supports peptide coupling chemistry in solid-phase or solution-phase workflows where a D-configured amino acid building block is required. The α-amino acid motif enables activation of the carboxyl group and formation of amide bonds, while the propargyl side chain remains available for orthogonal post-coupling modification. Protecting-group strategies can be applied to the amino and carboxyl functions to control chemoselectivity during chain assembly, with the D stereocenter preserved through standard protected amino acid synthesis and deprotection steps. Incorporation into peptides can generate alkyne-bearing analogs suitable for subsequent click-type conjugation or for probing backbone and side-chain effects on peptide conformation and reactivity. H-D-Pra-OH*HCl thus functions as a stereodefined amino acid intermediate for peptide construction and alkyne-enabled sequence diversification.

2. Bioconjugation Chemistry

H-D-Pra-OH*HCl is well suited to bioconjugation and chemical biology workflows that rely on alkyne handles for site-selective labeling. The propargyl side chain provides a defined reactive moiety that can participate in orthogonal coupling reactions after peptide or small-molecule assembly, while the amino acid backbone facilitates incorporation into biomolecule-affecting constructs. Salt-associated handling improves consistency during intermediate preparation, and downstream conversion to protected or activated derivatives can enable controlled conjugation onto proteins, peptides, or polymeric carriers. D stereochemistry can be used to tune resistance to proteolysis and to modulate molecular recognition in labeling experiments. H-D-Pra-OH*HCl therefore serves as a chiral alkyne-bearing amino acid precursor for constructing conjugation-ready biomolecular probes.

3. Peptidomimetics And SAR Studies

H-D-Pra-OH*HCl enables peptidomimetic design where a D-amino acid and a chemically addressable side chain are combined for structure-activity relationship investigations. The D-configuration at the α-carbon provides a stereochemical variable that can influence local backbone geometry and protease stability, while the terminal alkyne supports systematic side-chain functionalization. Derivatization of the propargyl group can be used to generate libraries of analogs with altered polarity, steric profile, or conjugation capacity, supporting SAR studies that correlate chemical modifications with measured binding or functional readouts in vitro. Protecting-group and activation strategies for the amino acid functionality allow controlled incorporation into analog scaffolds without premature side-chain consumption. H-D-Pra-OH*HCl thus functions as a chiral intermediate for iterative medicinal chemistry and peptidomimetic scaffold diversification.

4. Protected Amino Acid Intermediate

H-D-Pra-OH*HCl is a practical starting material for preparing protected D-propargylglycine derivatives used in peptide building block synthesis. The presence of both an amino acid carboxyl group and an α-amino functionality supports formation of N-protected amino acid derivatives (and, when required, carboxyl activation forms) that can withstand coupling conditions and minimize side reactions from the alkyne. Orthogonal protection schemes can be selected so that the propargyl side chain remains intact during peptide assembly, enabling later functionalization after deprotection or post-synthetic modification. The salt form can assist in consistent handling prior to conversion into coupling-ready protected intermediates, supporting reproducible manufacturing of chiral amino acid building blocks. H-D-Pra-OH*HCl therefore serves as a stereodefined chiral amino acid intermediate for downstream protected amino acid chemistry and peptide-grade reagent preparation.

5. Process Chemistry Intermediate

H-D-Pra-OH*HCl can be employed in process chemistry intermediate preparation for industrial fine chemical synthesis where a chiral alkyne amino acid is required. The molecular structure contains a single chiral center and a terminal alkyne, enabling downstream conversion into activated derivatives or protected forms that are compatible with scalable peptide coupling and intermediate isolation steps. Salt formation improves operational handling and can support aqueous workup and controlled neutralization strategies prior to activation, while the carboxylic acid functionality provides a clear handle for conversion into amide-forming intermediates. Side-chain reactivity is preserved through appropriate protection/activation planning, allowing manufacturing routes that separate amino acid assembly from later functional group installation. H-D-Pra-OH*HCl thus functions as a chiral, alkyne-bearing amino acid starting point for industrially relevant intermediate manufacturing and controlled downstream derivatization.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die